Clinical Trials Logo
  1. Home
  2. Rhinovirus
  3. NCT04489381

Trial to Evaluate Efficacy and Safety of Nitazoxanide in the Treatment of Colds Due to Enterovirus/Rhinovirus Infection

Rhinovirus Clinical Trial

Official title:
Phase 3, A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate Efficacy and Safety of Nitazoxanide in the Treatment of Colds Due to Enterovirus/Rhinovirus Infection

Clinical Trial Summary

Trial to evaluate the efficacy and safety of nitazoxanide in the treatment of colds due to enterovirus/rhinovirus infection

Clinical Trial Description

Multicenter, randomized, double-blind trial to evaluate the efficacy and safety of nitazoxanide in the treatment of colds due to enterovirus/rhinovirus infection ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04489381
Study type Interventional
Source Romark Laboratories L.C.
Contact Matthew Bardin
Phone 813-282-8544
Email matthew.bardin@romark.com
Status Recruiting
Phase Phase 3
Start date May 13, 2020
Completion date May 2025
View Details
See also
  Status Clinical Trial Phase
Completed NCT02984280 - Specific Respiratory Infections as Triggers of Acute Medical Events N/A
Completed NCT01158560 - A Trial of Vitamin D and Health Advice for the Prevention of Upper Respiratory Tract Infections Phase 3
Completed NCT03605862 - Efficacy and Safety of Nitazoxanide in the Treatment of Colds Due to Enterovirus/Rhinovirus Infection Phase 3
Recruiting NCT06149494 - RCT of Vapendavir in Patients With COPD and Human Rhinovirus/Enterovirus Upper Respiratory Infection Phase 2
Not yet recruiting NCT05348616 - Impact of the Covid-19 on RSV
Not yet recruiting NCT05348707 - Impact of Covid-19 on Rhinovirus Epidemic
Completed NCT04670627 - Biomarkers in Nasal Samples of Seasonal Allergic Rhinitics
Suspended NCT03508479 - Study of Airway Inflammatory Responses to Experimental Rhinovirus Infection Phase 1
Not yet recruiting NCT05348655 - Impact of the Covid-19 on RSV Epidemic in the Metropolis of Lyon
Completed NCT02438293 - 'The Impact of Rhinovirus Infections in Paediatric Cardiac Surgery'
Completed NCT05016687 - First-in-human Clinical Trial Evaluating CUR-N399 in Healthy Volunteers. Phase 1
Completed NCT02660489 - Effect of OC459 on the Response to Rhinovirus Challenge in Asthma Phase 2
Completed NCT02522832 - Discovering New Treatments for Asthma and COPD. A New Human Rhinvovirus for Human Challenge N/A
Completed NCT01302418 - Collection and Testing of Respiratory Samples N/A
Completed NCT01249625 - The Respiratory Protection Effectiveness Clinical Trial N/A
Completed NCT01175226 - A Phase 2 Study of BTA798 in Asthmatic Adults With Symptomatic Human Rhinovirus Infection Phase 2
Completed NCT00394914 - Effects of Pleconaril Nasal Spray on Common Cold Symptoms and Asthma Exacerbations Following Rhinovirus Exposure (Study P04295) Phase 2
Withdrawn NCT03024177 - A Study of Vapendavir Treatment of Hematopoietic Stem Cell Transplant Subjects With Symptomatic Rhinovirus Infection Phase 2